dc.contributor.author |
Schäfer, Sarah |
|
dc.contributor.author |
Behling, Felix |
|
dc.contributor.author |
Skardelly, Marco |
|
dc.contributor.author |
Koch, Marilin |
|
dc.contributor.author |
Ott, Ines |
|
dc.contributor.author |
Paulsen, Frank |
|
dc.contributor.author |
Tabatabai, Ghazaleh |
|
dc.contributor.author |
Schittenhelm, Jens Florian |
|
dc.date.accessioned |
2019-12-03T12:16:44Z |
|
dc.date.available |
2019-12-03T12:16:44Z |
|
dc.date.issued |
2018 |
|
dc.identifier.issn |
1365-2990 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/95245 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Wiley |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1111/nan.12447 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190321153956_03825 |
|
utue.publikation.seiten |
207-223 |
de_DE |
utue.personen.roh |
Schaefer, S. |
|
utue.personen.roh |
Behling, F. |
|
utue.personen.roh |
Skardelly, M. |
|
utue.personen.roh |
Koch, M. |
|
utue.personen.roh |
Ott, I. |
|
utue.personen.roh |
Paulsen, F. |
|
utue.personen.roh |
Tabatabai, G. |
|
utue.personen.roh |
Schittenhelm, J. |
|
dcterms.isPartOf.ZSTitelID |
Neuropathology and Applied Neurobiology |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
44 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |